Related references
Note: Only part of the references are listed.Off-Target Decoding of a Multitarget Kinase Inhibitor by Chemical Proteomics
Enrico Missner et al.
CHEMBIOCHEM (2009)
Logic Integer Programming Models for Signaling Networks
Utz-Uwe Haus et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2009)
Identifying Network of Drug Mode of Action by Gene Expression Profiling
Francesco Iorio et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2009)
Identifying the proteins to which small-molecule probes and drugs bind in cells
Shao-En Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
Birgit Schoeberl et al.
SCIENCE SIGNALING (2009)
Fuzzy Logic Analysis of Kinase Pathway Crosstalk in TNF/EGF/Insulin-Induced Signaling
Bree B. Aldridge et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Hypergraphs and Cellular Networks
Steffen Klamt et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
A short-term operational planning model for natural gas production systems
Ajay Selot et al.
AICHE JOURNAL (2008)
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents
M. Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Flexible informatics for linking experimental data to mathematical models via DataRail
Julio Saez-Rodriguez et al.
BIOINFORMATICS (2008)
Optimal automatic reaction and species elimination in kinetic mechanisms
A. Mitsos et al.
COMBUSTION AND FLAME (2008)
Models from experiments: combinatorial drug perturbations of cancer cells
Sven Nelander et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
High-throughput kinase profiling as a platform for drug discovery
David M. Goldstein et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Mass spectrometry-based functional proteomics: from molecular machines to protein networks
Thomas Kocher et al.
NATURE METHODS (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Boolean network analysis of a neurotransmitter signaling pathway
Simone Gupta et al.
JOURNAL OF THEORETICAL BIOLOGY (2007)
Structural and functional analysis of cellular networks with CellNetAnalyzer
Steffen Klamt et al.
BMC SYSTEMS BIOLOGY (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Literature mining for the biologist: from information retrieval to biological discovery
LJ Jensen et al.
NATURE REVIEWS GENETICS (2006)
The mode-of-action by network identification (MNI) algorithm: a network biology approach for molecular target identification
Heming Xing et al.
NATURE PROTOCOLS (2006)
A method for the generation of standardized qualitative dynamical systems of regulatory networks
Luis Mendoza et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2006)
Chemoproteomics-driven drug discovery: addressing high attrition rates
Steven E. Hall
DRUG DISCOVERY TODAY (2006)
Towards a proteome-scale map of the human protein-protein interaction network
JF Rual et al.
NATURE (2005)
Features of selective kinase inhibitors
ZA Knight et al.
CHEMISTRY & BIOLOGY (2005)
Can cell systems biology rescue drug discovery?
EC Butcher
NATURE REVIEWS DRUG DISCOVERY (2005)
Causal protein-signaling networks derived from multiparameter single-cell data
K Sachs et al.
SCIENCE (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Chemogenomic profiling on a genomewide scale using reverse-engineered gene networks
D di Bernardo et al.
NATURE BIOTECHNOLOGY (2005)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
A Bayesian networks approach for predicting protein-protein interactions from genomic data
R Jansen et al.
SCIENCE (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways
WL Xia et al.
ONCOGENE (2002)
Share Paper
